Inventor
Elversson Jessica
SE16 patents
Patents
16 patentsUS10975046B2Apr 13, 2021
Crystal modifications of odevixibat
ALBIREO AB22 citations93
US10786529B2Sep 29, 2020
Oral cholestyramine formulation and use thereof
ALBIREO AB12 citations85
US12091394B2Sep 17, 2024
Crystal modifications of odevixibat
ALBIREO AB4 citations84
US11801226B2Oct 31, 2023
Pharmaceutical formulation of odevixibat
ALBIREO AB11 citations84
US11802115B2Oct 31, 2023
Pharmaceutical formulation of odevixibat
ALBIREO AB11 citations84
US11365182B2Jun 21, 2022
Crystal modifications of odevixibat
ALBIREO AB10 citations84
US10441605B2Oct 15, 2019
Oral cholestyramine formulation and use thereof
ALBIREO AB6 citations83
US10441604B2Oct 15, 2019
Cholestyramine pellets and methods for preparation thereof
ALBIREO AB6 citations83
US11007142B2May 18, 2021
Oral cholestyramine formulation and use thereof
ALBIREO AB5 citations72
US10864228B2Dec 15, 2020
Oral cholestyramine formulation and use thereof
ALBIREO AB2 citations72
US10799527B2Oct 13, 2020
Oral cholestyramine formulation and use thereof
ALBIREO AB2 citations72
US10610543B2Apr 7, 2020
Cholestyramine pellets and methods for preparation thereof
ALBIREO AB4 citations72
US10722457B2Jul 28, 2020
Oral cholestyramine formulation and use thereof
ALBIREO AB1 citations62
US12508234B2Dec 30, 2025
Pharmaceutical formulation of odevixibat
ALBIREO AB0 citations61
US10758563B2Sep 1, 2020
Oral cholestyramine formulation and use thereof
ALBIREO AB0 citations51
US10493096B2Dec 3, 2019
Oral cholestyramine formulation and use thereof
ALBIREO AB0 citations51